Bold R J, Ishizuka J, Townsend C M, Thompson J C
Department of Surgery, University of Texas Medical Branch Galveston 77555.
Biochem Biophys Res Commun. 1994 Aug 15;202(3):1222-6. doi: 10.1006/bbrc.1994.2061.
Two receptors for cholecystokinin (CCK) have been isolated which also bind gastrin: CCK-A type and CCK-B type, both are coupled to phospholipase C (PLC) activation. However, identification of the "true" gastrin receptor remains controversial. We determined which CCK receptor mediated the trophic effect of gastrin on human colon cancer cells (LoVo). LoVo cells lack mRNA for either CCK receptor by Northern hybridization. Gastrin stimulated cyclic AMP production, not PLC activity, in LoVo cells. The trophic effect was not blocked by receptor antagonists for CCK-A (L364,718) or CCK-B (L365,260). The gastrin receptor pharmacology on LoVo cells and the lack of appropriate transcripts suggest that gastrin stimulated growth of these cells by a receptor other than CCK-A or CCK-B type and there likely exists another receptor for gastrin.
已分离出两种也能结合胃泌素的胆囊收缩素(CCK)受体:CCK - A型和CCK - B型,二者均与磷脂酶C(PLC)激活偶联。然而,“真正的”胃泌素受体的鉴定仍存在争议。我们确定了哪种CCK受体介导胃泌素对人结肠癌细胞(LoVo)的营养作用。通过Northern杂交,LoVo细胞缺乏任一CCK受体的mRNA。胃泌素刺激LoVo细胞中环磷酸腺苷(cAMP)的产生,而非PLC活性。CCK - A(L364,718)或CCK - B(L365,260)的受体拮抗剂并未阻断这种营养作用。LoVo细胞上胃泌素受体的药理学特性以及缺乏相应的转录本表明,胃泌素通过CCK - A或CCK - B型以外的受体刺激这些细胞生长,并且可能存在另一种胃泌素受体。